Rekenbi intravenous infusion 500 mg (lecanemab), manufactured by Eisai, is approved in Japan for slowing the progression of mild cognitive impairment and mild dementia due to Alzheimer’s disease. The YJ code is 1190408A2021 and the standard is 500mg 5mL 1 bottle.
Rekenbi intravenous infusion 500 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →